NorthCrest Asset Manangement’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
AT
CIM
AC
MPWT
CNB
LTAS
P
NorthCrest Asset Manangement's RMD Position: Q2 2026 in Review
NorthCrest Asset Manangement increased its ResMed (RMD) stake by 5.9% in Q2 2026, buying an estimated $496K and bringing the position to 42,753 shares worth $8.91M. The position accounts for 0.23% of the portfolio, ranked #107.
NorthCrest Asset Manangement first reported a position in RMD in Q4 2021 and has held it in 19 quarters since. The position peaked at $15.4M in Q3 2025. 90 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- NorthCrest Asset Manangement held 42,753 shares of ResMed worth $8.91M as of Q2 2026.
- NorthCrest Asset Manangement bought 2,393 ResMed shares in Q2 2026, an estimated $496K.
- ResMed made up 0.23% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #107 holding.
- NorthCrest Asset Manangement first reported a position in ResMed in Q4 2021 and has held it in 19 quarters since.
- NorthCrest Asset Manangement's ResMed position peaked at $15.4M in Q3 2025.
- 90 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.